A molecular assay for sensitive detection of pathogen-specific T-cells

Victoria O Kasprowicz1, Jessica E Mitchell, Shivan Chetty

  • 1Ragon Institute of MGH, MIT and Harvard, Harvard Medical School, Boston, Massachusetts, United States of America. vkasprowicz@partners.org

Plos One
|August 20, 2011
PubMed

Insights

A new, highly sensitive assay detects antigen-specific interferon-gamma (IFN-γ) production using quantitative PCR (qPCR). This method accurately identifies T-cell responses to infections like tuberculosis, even in HIV co-infected patients.

Area of Science:

  • Immunology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Interferon-gamma (IFN-γ) is a key cytokine in cell-mediated immunity.
  • Accurate measurement of antigen-specific IFN-γ is crucial for diagnosing and monitoring infectious diseases.
  • Existing assays may have limitations in sensitivity or applicability to certain patient populations.

Purpose of the Study:

  • To develop and validate a highly sensitive assay for measuring antigen-specific IFN-γ production.
  • To apply the assay for detecting immune responses to Cytomegalovirus (CMV), Human Immunodeficiency Virus (HIV), and Mycobacterium tuberculosis (MTB).
  • To compare the sensitivity of the new assay with the established IFN-γ Elispot assay.

Main Methods:

  • Development and validation of a real-time quantitative PCR (qPCR) assay.
  • Utilizing monokine-induced by IFN-γ (MIG) and IFN-γ inducible protein-10 (IP10) as reporters.
  • Application to whole blood samples from HIV co-infected patients.

Main Results:

  • The qPCR assay demonstrated high sensitivity for detecting MTB-specific T-cell responses.
  • A significant quantitative correlation was observed between the qPCR assay and the IFN-γ Elispot assay (P<0.001).
  • The assay successfully detected CMV, HIV, and MTB-specific responses and was not affected by HIV-mediated immunosuppression.

Conclusions:

  • The developed qPCR assay is a sensitive tool for detecting antigen-specific IFN-γ production.
  • The assay can be performed on small whole blood volumes (50 µL) obtained via fingerprick.
  • This assay platform holds potential utility for diagnosing infections in various clinical settings, including those with HIV co-infection.

Related Concept Videos